AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...
The UC Santa Cruz Alumni Association is proud to present this year’s UCSC Alumni Awards honorees: George M. Kraw, Keith Curry ...
including the departure of longtime CEO Jean-Jacques Bienaimé — replaced by former Genentech CEO Alexander Hardy — pressure from an activist investor to cut costs and doubts about some of the ...
Affimed N.V. AFMD announced that it has appointed Shawn M. Leland as the company’s new chief executive officer (CEO). Shares of the company were down 6.6% on Sep 3 following the announcement of the ...
All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...
Tim Cook Named CEO and Jobs Elected Chairman of the Board CUPERTINO ... s most innovative and valuable technology company,” said Art Levinson, Chairman of Genentech, on behalf of Apple’s Board. “Steve ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Leland most recently served as the interim CEO and board director of ForeBio ... revenues related to a platform license provided to Genentech, a subsidiary of Swiss drug giant Roche RHHBY.
She will report to Teresa Graham, CEO of Roche Pharma, and become a member of the group’s pharma leadership team. “Ashley is a Roche and Genentech veteran, with a 20-year career that spans the ...
Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...
Roche has filled the open CEO position at Genentech with Alexander Hardy, a veteran of the subsidiary. The position has been open since previous CEO Bill Anderson left to head up Roche’s ...
Opens in a new tab or window The former CEO of Liveyon -- the stem cell company ... In 2016, Kosolcharoen created Genetech (not to be confused with Genentech) and Liveyon to manufacture and ...